S1PR1 and cancer: This drug has been used as a novel immunosuppressive agent to inhibit S1P1-mediated immune cell migration from lymph to sites of inflammation and is of particular interest in transplant and in treatment of autoimmune diseases such as multiple sclerosis [9] and more recently, cancer.